David R. Borcherding

1.7k citations

29 papers · 1.5k indexed · h-index 19

Impact in

Physiology top 1%
- Adenosine and Purinergic Signaling
Organic Chemistry top 5%
- Asymmetric Synthesis and Catalysis
- Synthetic Organic Chemistry Methods
- Carbohydrate Chemistry and Synthesis
- Synthesis and Catalytic Reactions

Papers in

Physiology 6
- Adenosine and Purinergic Signaling 5
Organic Chemistry 10
- Carbohydrate Chemistry and Synthesis 4
- Synthetic Organic Chemistry Methods 3
- Asymmetric Synthesis and Catalysis 3
- Synthesis and Biological Evaluation 3

Co-authors: Jeffrey S. Sabol Philip M. Weintraub John M. Kane Ronald T. Borchardt Carl K. Edwards Michael S. Wolfe R. T. BORCHARDT Michael J. Parmely
Journals: Journal of Medicinal Chemistry (5 papers)The Journal of Immunology (3 papers)The Journal of Organic Chemistry (3 papers)Tetrahedron Letters (2 papers)Antimicrobial Agents and Chemotherapy (2 papers)
Partner nations: United States Belgium France

In The Last Decade

David R. Borcherding

29 papers receiving 1.4k citations

Peers

Countries citing papers authored by David R. Borcherding

Since Specialization

Citations

This map shows the geographic impact of David R. Borcherding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David R. Borcherding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David R. Borcherding more than expected).

Fields of papers citing papers by David R. Borcherding

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David R. Borcherding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David R. Borcherding. The network helps show where David R. Borcherding may publish in the future.

Co-authors

The 25 scholars most cited alongside David R. Borcherding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David R. Borcherding Line = papers co-authored together David R. Borcherding links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Recent advances in the synthesis of piperidones and piperidines Tetrahedron ·Philip M. Weintraub, Jeffrey S. Sabol, John M. Kane, David R. Borcherding	2003	409
2	Recent Advances in the Synthesis of Piperidones and Piperidines ChemInform ·Philip M. Weintraub, Jeffrey S. Sabol, John M. Kane, David R. Borcherding	2003	1
3	THE DESIGN AND SYNTHESIS OF PURINE INHIBITORS OF CDK2. III Nucleosides Nucleotides & Nucleic Acids ·A Farj, Norton P. Peet, Philip M. Weintraub, Catherine M Scott, GiosuèDella Porta, Francis P. Barbone, 淑子小原, А.П. Савельев, Scott D. Dwyer, Dian Li, Elaine A. Powers, Kurt Kropp, Paul S. Wright, Alan J. Bitonti, Jennifer Dumont, David R. Borcherding	2001	14
4	A stereocontrolled approach to substituted piperidones and piperidines: flavopiridol D-ring analogs Tetrahedron Letters ·K. Laker, David R. Borcherding, Dirk Friedrich, Jeffrey S. Sabol	2001	22
5	The Synthesis and Biological activity of a Highly Selective Adenosine A_2a. Receptor Agonist Nucleosides and Nucleotides ·David R. Borcherding, Marcus Vinícius de Sousa Lopes, Philip M. Weintraub, Mark W. Dudley, Roberta J. Secrest, Philip R. Kastner, Norton P. Peet, Schmickal Th.	1999	2
6	Activation of adenosine A3 receptors on macrophages inhibits tumor necrosis factor-α European Journal of Pharmacology ·Charlene D. McWhinney, Mark W. Dudley, Terry L. Bowlin, Norton P. Peet, Lawrence B. Schook, Marita Bradshaw, Mamata De, David R. Borcherding, Carl K. Edwards	1996	103
7	ChemInform Abstract: cis‐(1S,3R)‐1‐(9‐Adenyl)‐3‐hydroxycyclopentane Inhibits the Respiratory Burst from Polymorphonuclear Leukocytes and Has in vivo Efficacy in an Acute and Chronic Model of Inflammation. ChemInform ·David R. Borcherding, C. M. Senavirathne, Matthew D. Linnik, Mehdi Stiti, Mark W. Dudley, Carl K. Edwards	1996	1
8	Adenosine A3 receptor agonists inhibit macrophage tumor necrosis factor-? production Drug Development Research ·Terry L. Bowlin, David R. Borcherding, Carl K. Edwards, Charlene D. McWhinney	1996	5
9	Specific transcriptional inhibition of bone marrow-derived macrophage tumor necrosis factor-alpha gene expression and protein production using novel enantiomeric carbocyclic nucleoside analogues. Journal of Pharmacology and Experimental Therapeutics ·もえ花園, Mark S. Rutherford, Z Weng, Charlene D. McWhinney, David R. Borcherding, Lawrence B. Schook, Carl K. Edwards	1995	14
10	Increased susceptibility of fas mutant MRL-lpr/lpr mice to staphylococcal enterotoxin B-induced septic shock The Journal of Immunology ·John D. Mountz, 周文翰, David R. Borcherding, Horst Bluethmann, Kurt von Ashe, Carl K. Edwards	1995	27
11	AMP Deaminase as a Novel Practical Catalyst in the Synthesis of 6-Oxopurine Ribosides and their Analogs The Journal of Organic Chemistry ·Alexey L. Margolin, David R. Borcherding, Dinora Ferreira Bastos, Nara Margolin	1994	23
12	Effect of the carbocyclic nucleoside analogue MDL 201,112 on inhibition of interferon-γ-induced priming of Lewis (LEW/N) rat macrophages for enhanced respiratory burst and MHC class II Ia+ antigen expression Journal of Leukocyte Biology ·Carl K. Edwards, Lynnetta M. Watts, Michael J. Parmely, Matthew D. Linnik, Louise De Clerck, David R. Borcherding	1994	22
13	The resolution, isolation, and pharmacological characterization of the enantiomers of a benzamide containing a chiral sulfoxide Chirality ·C. M. Senavirathne, Ruoxi Li, Medicaid Services, David R. Borcherding, K. Vinod Kumar, Andrew T. McPhail, Donna M. Radzik, Hans Wynberg, Wolter ten Hoeve, Erik van Echten, Nahed K. Ahmed, Matthew D. Linnik	1992	9
14	4'-Modified analogs of aristeromycin and neplanocin A: synthesis and inhibitory activity toward S-adenosyl-L-homocysteine hydrolase Journal of Medicinal Chemistry ·Michael S. Wolfe, Leenh O. BaHammam, Liang Chen, David R. Borcherding, Ronald T. Borchardt	1992	51
15	Enantiospecific syntheses of aristeromycin and neplanocin A The Journal of Organic Chemistry ·Michael S. Wolfe, Blake Anderson, David R. Borcherding, Ronald T. Borchardt	1990	51
16	Potential inhibitors of S-adenosylmethionine-dependent methyltransferases. 11. Molecular dissections of neplanocin A as potential inhibitors of S-adenosylhomocysteine hydrolase Journal of Medicinal Chemistry ·David R. Borcherding, Venoso Drenaje, Masahide Hasobe, Yan Jishu, Bradley T. Keller, Ronald T. Borchardt	1988	53
17	9-(Trans-2'-trans-3'-dihydroxycyclopent-4'-enyl) derivatives of adenine and 3-deazaadenine: potent inhibitors of bovine liver S-adenosylhomocysteine hydrolase Journal of Medicinal Chemistry ·Yung Soon Lee, Bradley T. Keller, David R. Borcherding, Ray Covington, R. T. BORCHARDT	1988	39
18	Effects of 9-(trans-2',trans-3'-dihydroxycyclopent-4'-enyl)-adenine and -3-deazaadenine on the metabolism of S-adenosylhomocysteine in mouse L929 cells. Molecular Pharmacology ·Masahide Hasobe, Yan Jishu, David R. Borcherding, B T Keller, R. T. BORCHARDT	1988	25
19	9-(trans-2',trans-3'-Dihydroxycyclopent-4'-enyl)-adenine and -3-deazaadenine: analogs of neplanocin A which retain potent antiviral activity but exhibit reduced cytotoxicity Antimicrobial Agents and Chemotherapy ·Masahide Hasobe, Yan Jishu, David R. Borcherding, R. T. BORCHARDT	1987	45
20	Synthesis of analogs of neplanocin A: utilization of optically active dihydroxycyclopentenones derived from carbohydrates The Journal of Organic Chemistry ·David R. Borcherding, Ray Covington, Ronald T. Borchardt	1987	82

About David R. Borcherding

David R. Borcherding is a scholar working on Physiology, Organic Chemistry, Immunology, Oncology and Rheumatology, having authored 29 papers that have together received 1.5k indexed citations. Recurring topics across this work include Biochemical and Molecular Research (9 papers), Immune Response and Inflammation (6 papers), Adenosine and Purinergic Signaling (5 papers), Folate and B Vitamins Research (4 papers), Carbohydrate Chemistry and Synthesis (4 papers), Synthetic Organic Chemistry Methods (3 papers), Asymmetric Synthesis and Catalysis (3 papers) and Synthesis and Biological Evaluation (3 papers). The work is most often cited by research in Physiology (223 citations), Organic Chemistry (680 citations), Infectious Diseases (216 citations), Immunology (209 citations) and Molecular Biology (600 citations). David R. Borcherding has collaborated with scholars based in United States, Belgium and France. Frequent co-authors include Jeffrey S. Sabol, Philip M. Weintraub, John M. Kane, Ronald T. Borchardt, Carl K. Edwards, Michael S. Wolfe, R. T. BORCHARDT, Michael J. Parmely, Masahide Hasobe and Richard Silverstein. Their work appears in journals such as Journal of Medicinal Chemistry, The Journal of Immunology, The Journal of Organic Chemistry, Tetrahedron Letters and Antimicrobial Agents and Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact